Browsing the "Fidelity Biosciences" Tag →

21 2015 April
By FinSMEs
0 Comments

Dimension Therapeutics Completes $65M Series B Financing

Dimension Therapeutics, Inc., a Cambridge, MA-based rare disease company advancing novel, liver-directed treatments for diverse genetic disorders, completed a $65m...

Read More →
02 2015 April
By FinSMEs
0 Comments

Quartet Health Raises $7M in Funding

Quartet Health Inc., a New York-based behavioral health technology company, raised $7m in funding. The round was led by Annie...

Read More →
02 2015 April
By FinSMEs
0 Comments

Caribou Biosciences Closes $11M Series A Financing Round

Caribou Biosciences, a Berkeley, Calif.-based developer of technology-based solutions for cellular engineering and analysis, closed an $11m Series A financing...

Read More →
24 2015 March
By FinSMEs
0 Comments

Semma Therapeutics Closes $44M Series A Funding

Semma Therapeutics, a Cambridge, MA-based developer of a cell therapy for Type 1 diabetes, closed a $44m Series A funding....

Read More →
02 2015 March
By FinSMEs
0 Comments

Mersana Therapeutics Raises $35M in Series B-1 Financing

Mersana Therapeutics, Inc., a Cambridgre, MA-based drug developer, raised $35m in Series B-1 financing. The round was led by existing...

Read More →
18 2015 February
By FinSMEs
0 Comments

TraceLink Raises $20M in Venture Funding

TraceLink Inc., a Wakefield, MA-based provider of solutions for Life Sciences companies to protect patients From counterfeit drugs, raised $20m...

Read More →
26 2015 January
By FinSMEs
0 Comments

Iora Health Raises $28M in Series C Funding

Iora Health, a Cambridge, Massachusetts-based healthcare company, raised $28m in Series C funding. Backers included Foundation Medical Partners, Rice Management...

Read More →
22 2015 January
By FinSMEs
0 Comments

Innovent Biologics Raises $100M in Series C Financing

Innovent Biologics, Inc., a Shangai, China-based biopharmaceutical company, raised $100m in Series C financing. The round was led by Legend...

Read More →
21 2015 January
By FinSMEs
0 Comments

Regenxbio Closes $30M in Series C Funding

Regenxbio, a Washington, DC-based gene therapy biotech company, closed $30m in Series C funding. The round was led by Venrock...

Read More →
08 2015 January
By FinSMEs
0 Comments

Surface Oncology Closes $35M Series A Funding Round

Surface Oncology, a Cambridge, Mass.-based company developing cancer immunotherapies, closed a $35m Series A funding round. Backers included The Atlas...

Read More →
09 2014 December
By FinSMEs
0 Comments

Adagene Raises $8M in Series A Funding

Adagene, a Suzhou Industrial Park, China-based biotech company, raised $8m in Series A funding. Backers included Fidelity Biosciences, Fidelity Asia...

Read More →
19 2014 November
By FinSMEs
0 Comments

Novaerus Completes $10M Funding Round

Novaerus, a Chicago, IL- and Dublin, Ireland-based company that applies plasma-based, airborne pathogen control technology to improve the business and quality...

Read More →
12 2014 November
By FinSMEs
0 Comments

Blueprint Medicines Completes $50M Series C Financing

Blueprint Medicines, a Cambridge, MA-based developer of selective kinase inhibitors for genomically defined cancers, completed a $50m Series C financing....

Read More →
21 2014 October
By FinSMEs
0 Comments

Unum Therapeutics Raises $12M in Series A Funding

Unum Therapeutics, a Cambridge, MA-based company developing cellular immunotherapy to treat cancer, raised $12m in Series A funding. The round...

Read More →